{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:19:09Z","timestamp":1769872749228,"version":"3.49.0"},"reference-count":105,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005483","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T11:54:39Z","timestamp":1128686079000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anabolic steroids for the treatment of weight loss in HIV-infected individuals"],"prefix":"10.1002","volume":"2010","author":[{"given":"Karen KJ","family":"Johns","sequence":"first","affiliation":[{"name":"Health Canada; Bureau of Metabolism, Oncology, and Reproductive Sciences of the Therapeutic Products Directorate; Finance Building Tunney's Pasture Ottawa Ontario Canada K1H 5T1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MJ","family":"Beddall","sequence":"additional","affiliation":[{"name":"664 Sandra Ave Ottawa Ontario Canada K1G 2Z8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RC","family":"Corrin","sequence":"additional","affiliation":[{"name":"Therapuetic Products Directorate, Health Canada; Bureau of Gastroenterology, Infection and Viral Diseases; Finance Building, Tunney's Pasture Ottawa Ontario Canada K1A 1B9"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,19]]},"reference":[{"key":"10.1002\/14651858.CD005483-BIB0001|cit1","first-page":"3155","article-title":"Effects of testosterone replacement with a nongenital transdermal system, Androderm, in Human Immunodeficiency Virus-infected men with low testosterone levels","volume":"83","author":"Bhasin","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.283.6.763","article-title":"Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels","volume":"283","author":"Bhasin","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005483-BIB0003|cit3","unstructured":"Bucher G Berger DS Fields-Gardner C Jones R Reiter WM A prospective study on the safety and effect of nandrolone decanoate in HIV-positive patients Int Conf AIDS 1996 26 (abstract Mo.B. 423)"},{"issue":"3","key":"10.1002\/14651858.CD005483-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1210\/jc.2004-1677","article-title":"Effects of testosterone replacement in Human Immunodeficiency Virus-infected women with weight loss","volume":"90","author":"Choi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00002030-199711000-00008","article-title":"A trial of testosterone therapy for HIV-associated weight loss","volume":"11","author":"Coodley","year":"1997","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9343(99)00193-X","article-title":"The use of transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection","volume":"107","author":"Dobs","year":"1999","journal-title":"Am J Med"},{"key":"10.1002\/14651858.CD005483-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archinte.164.8.897","article-title":"Effects of testosterone administration in Human Immunodeficiency Virus-infected women with low weight","volume":"164","author":"Dolan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD005483-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-129-1-199807010-00005","article-title":"Effects of androgen adminstration in men with the AIDS wasting syndrome","volume":"129","author":"Grinspoon","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD005483-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-133-5-200009050-00010","article-title":"Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting","volume":"133","author":"Grinspoon","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD005483-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00002030-200303280-00008","volume":"17","author":"Hengge","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0011|cit11","unstructured":"BID dose"},{"issue":"8","key":"10.1002\/14651858.CD005483-BIB0012|cit12","first-page":"2717","article-title":"Transdermal testosterone adminstration in women with acquired immunodeficiency syndrome wasting: a pilot study","volume":"83","author":"Miller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1002\/14651858.CD005483-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archinte.165.5.578","article-title":"Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"165","author":"Mulligan","year":"2005","journal-title":"Archives Internal Medicine"},{"issue":"14","key":"10.1002\/14651858.CD005483-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.281.14.1282","article-title":"Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial","volume":"281","author":"Strawford","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005483-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0271-5317(00)00253-0","article-title":"A randomized comparative trial of testosterone and protein supplements for weight loss in HIV plus men","volume":"21","author":"Wagner","year":"2001","journal-title":"Nutrition Research"},{"key":"10.1002\/14651858.CD005483-BIB0016|cit16","unstructured":"Batterham M Garcia R Randomised prospective medium-term comparison of megestrol acetate, nandrolone decanoate and dietary therapy alone for HIV associated wight loss Annu Conf Australas Soc HIV Med 1997 91 (Abstract no. IS 87)"},{"key":"10.1002\/14651858.CD005483-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Batterham M Garsia R A comparison of megesterol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss Int J Andrology 2001 232 40","DOI":"10.1046\/j.1365-2605.2001.00291.x"},{"key":"10.1002\/14651858.CD005483-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00007611-199308000-00003","article-title":"Effect of anabolic steroids on HIV-related wasting myopathy","volume":"86","author":"Berger","year":"1993","journal-title":"South Med J"},{"issue":"14","key":"10.1002\/14651858.CD005483-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/00002030-199612000-00010","article-title":"Oxandrolone in AIDS-wasting myopathy","volume":"10","author":"Berger","year":"1996","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0020|cit20","unstructured":"Carroll E Sauer L Pharo AN Vergel N Oxandrolone: anabolic steroid use in HIV positive women Natl Conf Women HIV 1997 107 (Abstract no. 103.4)"},{"key":"10.1002\/14651858.CD005483-BIB0021|cit21","doi-asserted-by":"crossref","unstructured":"Corcoran C Grinspoon S Anderson E Stanley T Rosenthal D Basgoz N Klibanski A Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting Int Conf AIDS 2000 Abstract no WePpB1383","DOI":"10.7326\/0003-4819-133-5-200009050-00010"},{"key":"10.1002\/14651858.CD005483-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Dolan S Wilkie S Aliabadi N Sullivan M Basgoz N Davis B Grinspoon S Effects of testosterone administration in HIV-infected women with low weight: a randomized, placebo-controlled study 11th Conf Retrovir Opportunistic Infect 2004 Abstract no. 151","DOI":"10.1001\/archinte.164.8.897"},{"issue":"6","key":"10.1002\/14651858.CD005483-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0148607102026006357","article-title":"Body cell mass repletion and improved quality of life in HIV-infected individuals receiving oxandrolone","volume":"26","author":"Earthman","year":"2002","journal-title":"JPEN"},{"key":"10.1002\/14651858.CD005483-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00042560-199604150-00012","article-title":"Effects of testosterone upon body composition","volume":"11","author":"Engelson","year":"1996","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/14651858.CD005483-BIB0025|cit25","first-page":"2020","article-title":"Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome","volume":"86","author":"Fairfield","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1152\/jappl.2001.90.6.2166","article-title":"Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting","volume":"90","author":"Fairfield","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1002\/14651858.CD005483-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"Fisher A Abbaticola M Effects of oxandrolone and 1-glutamine on body weight, body cell mass, and body fat in patients with HIV infection-preliminary analysis Conf Retroviruses Opportunistic Infect, 4th 1997 192 (Abstract no. 692)","DOI":"10.1016\/S0899-9007(97)82663-9"},{"key":"10.1002\/14651858.CD005483-BIB0028|cit28","unstructured":"Fisher AE Abbaticola MM Effects of oxandrolone on body weight and composition in patients with HIV-associated weight loss 5th Conf Retrovir Oppor Infect 1998 169 (Abstract no. 477)"},{"key":"10.1002\/14651858.CD005483-BIB0029|cit29","unstructured":"Fisher A Abbatilola M The effects of oxandrolone on body weight and composition in patients with HIV-associated weight loss Int Conf AIDS 1998 844 (Abstract no. 42351)"},{"issue":"6","key":"10.1002\/14651858.CD005483-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.104.6.e73","article-title":"Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients","volume":"104","author":"Fox-Wheeler","year":"1999","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD005483-BIB0031|cit31","unstructured":"Garsia R Batterham M Randomized prospective medium-term comparison of megestrolacetate, nandrolone decanoate and dietary therapy alone for HIV associated weight loss Annu Conf Australas Soc HIV Med, 9 1997 91 (Abstract no. IS 87)"},{"key":"10.1002\/14651858.CD005483-BIB0032|cit32","first-page":"unnumbered post","article-title":"The effect of the anabolic steroid, nandrolone decanoate, on lean body mass and qulaity of life in HIV+ men - a preliminary analysis","volume":"264","author":"Gold","year":"1994","journal-title":"Annu Conf Australas Soc HIV Med"},{"issue":"7","key":"10.1002\/14651858.CD005483-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00002030-199606001-00008","article-title":"Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection","volume":"10","author":"Gold","year":"1996","journal-title":"AIDS"},{"issue":"8","key":"10.1002\/14651858.CD005483-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/095646249901000814","article-title":"Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: a pilot study","volume":"10","author":"Gold","year":"1999","journal-title":"Int J STD AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0035|cit35","unstructured":"Gold J Phanuphak P Castelo A The use of nandrolone decanoate in patients with HIV wasting: a double blind, placebo controlled trial inThailand and Brazil Annu Conf Australas Soc HIV Med 1999 Abstract no P55"},{"key":"10.1002\/14651858.CD005483-BIB0036|cit36","first-page":"4251","article-title":"Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting","volume":"83","author":"Grinspoon","year":"1998","journal-title":"J Clin Edocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Grinspoon SK Corcoran C Anderson E Schoenfeld D Basgoz N Klibanski A Long-term effects of androgen administration in men with AIDS wasting Int Conf AIDS 1998 555 (abstract no. 32176)","DOI":"10.7326\/0003-4819-129-1-199807010-00005"},{"key":"10.1002\/14651858.CD005483-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/515162","article-title":"Sustained anabolic effects of long-term androgen administration in men with AIDS wasting","volume":"28","author":"Grinspoon","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1002\/14651858.CD005483-BIB0039|cit39","first-page":"60","article-title":"Effects of hypogonadism and testoterone administration on depression indices in HIV-infected men","volume":"85","author":"Grinspoon","year":"2000","journal-title":"J Clin Edocrinol Metab"},{"issue":"11","key":"10.1002\/14651858.CD005483-BIB0040|cit40","first-page":"35","article-title":"Anabolic therapy in AIDS patients","volume":"71","author":"Gruzdev","year":"1999","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD005483-BIB0041|cit41","first-page":"Abstract no PB0","article-title":"DHEA: a potential treatment for HIV disease","volume":"223","author":"Hasheeve","year":"1994","journal-title":"Int Conf AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Hellerstein MK Strawford A Barton N King J Barbieri T Van Loan M Parks EJ The effects of oxandrolone (OX) plus resistance exercise (RE) on nitrogen balance (N BAL), body composition and strength in men with AIDS wasting syndrome (AWS) Int Conf AIDS, 12 1998 841","DOI":"10.1016\/S0899-9007(97)82620-2"},{"issue":"1","key":"10.1002\/14651858.CD005483-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1079\/BJN19960116","article-title":"Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection","volume":"75","author":"Hengge","year":"1996","journal-title":"Brit J Nutr"},{"key":"10.1002\/14651858.CD005483-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"Hengge UR Baumann M Maleba R Brockmeyer N Goos M Oxymetholone promotes significant weight gain in patients with advanced HIV-1 infection 3rd Conf Retro and Opportun Infect 1996 126","DOI":"10.1079\/BJN19960116"},{"key":"10.1002\/14651858.CD005483-BIB0045|cit45","unstructured":"Hengge UR Stocks K Unger S Faulkenr S Goos M Dudley R Randomized phase III trial of oxmetholone for the treatment of HIV wasting and lipodystrophy Conf Retroviruses Opportunistic Infect 2002 Abstract No 705-T"},{"key":"10.1002\/14651858.CD005483-BIB0046|cit46","first-page":"150","article-title":"Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women","volume":"4","author":"Hengge","year":"2003","journal-title":"HIV Clin Trials"},{"key":"10.1002\/14651858.CD005483-BIB0047|cit47","article-title":"Oxymetholone for the treatment of HIV wasting: a double-blind, randomized, placebo-controlled phase 3 trial in eugonadal men and women","volume":"Abstract no 725","author":"Hengge","year":"2004","journal-title":"11th Conf Retrovir Opportunistic Infect"},{"key":"10.1002\/14651858.CD005483-BIB0048|cit48","first-page":"454(abstract no","article-title":"Low levels of testosterone in AIDS wasting syndrome. The effect of anabolic steroids on muscular body mass and better nutritional support","volume":"11(2)","author":"Hernandez-Lopez","year":"1996","journal-title":"Int Conf AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0049|cit49","first-page":"50","article-title":"Magnitude and timing of regional body composition changes during anabolic therapies in HIV-positive men","volume":"4","author":"Jaque","year":"2002","journal-title":"Clinical Exercise Physiology"},{"key":"10.1002\/14651858.CD005483-BIB0050|cit50","first-page":"71","article-title":"weight gain under oral testosterone undecanoate in AIDS","volume":"48","author":"Jeantils","year":"1993","journal-title":"Therapie"},{"issue":"2","key":"10.1002\/14651858.CD005483-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/apc.1993.7.68","article-title":"Treating HIV\/AIDS patients with anabolic steroids","volume":"7","author":"Jekot","year":"1993","journal-title":"AIDS Patient Care"},{"key":"10.1002\/14651858.CD005483-BIB0052|cit52","unstructured":"Klibanski A Basgoz N Schoenfeld D Grinspoon SK Corcoran C Anderson E Long-term effects of androgen adminstration in men with AIDS wasting Int Conf AIDS, 12 1998 555"},{"key":"10.1002\/14651858.CD005483-BIB0053|cit53","unstructured":"Mooney M Salvato P Vergel NR Anabolic steroids, resistance exercise and protein supplementation effect on lean body mass in HIV+ patients Int Conf AIDS, 12 1998 557"},{"key":"10.1002\/14651858.CD005483-BIB0054|cit54","first-page":"236(abstract no","article-title":"Nandrolone decanoate increases weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"8","author":"Mulligan","year":"2001","journal-title":"Conf Retroviruses Opportunistic Infect"},{"issue":"6","key":"10.1002\/14651858.CD005483-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/381977","article-title":"Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months","volume":"38","author":"Mwamburi","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1002\/14651858.CD005483-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/0115426504019004395","article-title":"Combination megestrol acetate, oxandrolone, and dietary advice restores weight in human immunodeficiency virus","volume":"19","author":"Mwamburi","year":"2004","journal-title":"Nutr Clin Pract"},{"key":"10.1002\/14651858.CD005483-BIB0057|cit57","article-title":"The use of nandrolone decanoate in patients with HIV wasting: a double-blind, placebo controlled trial in Thailand and Brazil","author":"Phanuphak","journal-title":"Provided by Organon International"},{"key":"10.1002\/14651858.CD005483-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Pharo AN Vergel N Carroll E Sauer L Oxandrolone: anabolic steroid use in HIV positive women Natl Conf Women HIV 1997 107 (Abstract no. 103.4)","DOI":"10.1016\/S0899-9007(97)82622-6"},{"key":"10.1002\/14651858.CD005483-BIB0059|cit59","unstructured":"Poles MA Meller JA Lin A Weiss WR Gocke M Dietrich DT Oxandrolone as a treatment for AIDS-related weight loss and wasting 4th Conf Retro and Opportun Infect 1997 193 (Abstract no. 695)"},{"key":"10.1002\/14651858.CD005483-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0163-8343(94)00062-I","article-title":"Testosterone replacement therapy in HIV illness","volume":"17","author":"Rabkin","year":"1995","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1002\/14651858.CD005483-BIB0061|cit61","first-page":"136","article-title":"Testosterone replacement therapy for HIV infected men","volume":"5","author":"Rabkin","year":"1995","journal-title":"AIDS Reader"},{"issue":"1","key":"10.1002\/14651858.CD005483-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02903936","article-title":"Treatment of depression in HIV+ men: literature review and report of an ongoing study of testosterone replacement therapy","volume":"18","author":"Rabkin","year":"1996","journal-title":"Ann Behavioral Med"},{"issue":"1","key":"10.1002\/14651858.CD005483-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004714-199902000-00006","article-title":"Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism","volume":"19","author":"Rabkin","year":"1999","journal-title":"J Clin Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005483-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4530(99)00036-0","article-title":"DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters","volume":"25","author":"Rabkin","year":"2000","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1002\/14651858.CD005483-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archpsyc.57.2.141","article-title":"A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms","volume":"57","author":"Rabkin","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005483-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.jcp.0000132442.35478.3c","article-title":"Testosterone versus fluoxetine for depression and fatigue in HIV\/AIDS: a placebo-controlled trial","volume":"24","author":"Rabkin","year":"2004","journal-title":"J Clin Psychpharmcol"},{"key":"10.1002\/14651858.CD005483-BIB0067|cit67","unstructured":"Reiter WM Jones R Fields-Gardner C Berger DS Bucher G A prospective study on the safety and effect of nandrolone decanoate in HIV-positive patients Int Conf AIDS 1996 26 (Abstract no. Mo.B.423"},{"key":"10.1002\/14651858.CD005483-BIB0068|cit68","unstructured":"Rivers S Horton R Sattler F Qian D Olson C Briggs W Bhasin S Block in the generation of dihydrotestosterone from testosterone in patients with weight loss Conf Retroviruses Opportunistic Infect 6th 1999 200 (Abstract no. 701)"},{"issue":"2","key":"10.1002\/14651858.CD005483-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jama.284.2.176","article-title":"Resistance exercise and oxandrolone for men with HIV-related weight loss [letter]","volume":"284","author":"Romeyn","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD005483-BIB0070|cit70","first-page":"1268","article-title":"Effects of pharmacologic doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus","volume":"84","author":"Sattler","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0071|cit71","unstructured":"Sattler F Jaque SV Schroeder ET Horton R Dube M Briggs W Effects of pharmacological doses of nandrolone decanoate and progressive resistance training during HIV immunodeficiency Conf Retroviruses Opportunistic Infect, 6th 1999 200"},{"key":"10.1002\/14651858.CD005483-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1152\/ajpendo.00189.2002","article-title":"Metabolic effects of nandrolone decanoate and resistance training in men with HIV","volume":"283","author":"Sattler","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0073|cit73","first-page":"236 (Abstract n","article-title":"Effect of testosterone (T) on the response to megesterol acetate (MA) in patients with HIV-associated wasting: a randomized, double-blind placebo-controlled trial (ACTG 313)","volume":"8","author":"Schambelan","year":"2001","journal-title":"Conf Retroviruses Opportunistic Infect"},{"key":"10.1002\/14651858.CD005483-BIB0074|cit74","unstructured":"Schrader S Vergel N A randomized, open label, controlled study on the use of ananbolic steroids, nutritional supplementation and exercise for HIV-positive males Int Conf AIDS 2002 Abstract no. B10287"},{"key":"10.1002\/14651858.CD005483-BIB0075|cit75","unstructured":"Schroeder ET Jaque SV Hawkins SA Olson C Regional DXA in assessment of muscle adaptation to anabolic stimuli 2001 199 206"},{"issue":"1","key":"10.1002\/14651858.CD005483-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1152\/ajpendo.00032.2003","article-title":"Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies","volume":"285","author":"Schroeder","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0077|cit77","unstructured":"Strawford A Barbieri T Van Loan M Parks EJ King J Barton N The effects of oxandrolone (OX) plus resistance exercise (RE) on nitrogen balance (N BAL), body composition and strength in men with AIDS wasting syndrome (AWS) Int Conf AIDS 1998 841 (Abstract no. 42335)"},{"key":"10.1002\/14651858.CD005483-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042560-199902010-00005","article-title":"Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss","volume":"20","author":"Strawford","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1002\/14651858.CD005483-BIB0079|cit79","unstructured":"Stute A Poppinger J Spitz S Jaegel Guedes E Jaegel H Treatment with medroxy-progesterone-acetate reverses weight loss but not body cell mass depletion: results of body-impedance analysis Int Conf AIDS 1994 223 (abstract no. PB0907)"},{"key":"10.1002\/14651858.CD005483-BIB0080|cit80","unstructured":"Umar S Feleke G Roginsky MS Schaeffer P Effect of dehydroepiandosterone (DHEA) on clinical and laboratory parameters in female patients with AIDS (FPWA) Int Conf AIDS 1998 848 (Abstract no. 42373)"},{"key":"10.1002\/14651858.CD005483-BIB0081|cit81","unstructured":"Urbina A Miller M Hance I Oxymetholone as therapy to maintain body composition in HIV positive men Int Conf AIDS 2004 Abstract no. B12432"},{"key":"10.1002\/14651858.CD005483-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00002030-199902040-00012","article-title":"Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy","volume":"13","author":"Loan","year":"1999","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0083|cit83","unstructured":"Vergel NR Salvato P Mooney M Anabolic steroids, resistance exercise and protein supplementation effect on lean body mass in HIV+ patients Int Conf AIDS 1998 557 (Abstract no. 32185)"},{"issue":"4","key":"10.1002\/14651858.CD005483-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0163-8343(98)00024-3","article-title":"Testosterone as treatment for fatigue in HIV+ men","volume":"20","author":"Wagner","year":"1998","journal-title":"Gen Hosp Psych"},{"issue":"1","key":"10.1002\/14651858.CD005483-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1258\/0956462981921639","article-title":"Testosterone therapy for clinical symptoms of hypogonadism in eugonadal men with AIDS","volume":"9","author":"Wagner","year":"1998","journal-title":"Int J STD AIDS"},{"issue":"6","key":"10.1002\/14651858.CD005483-BIB0086|cit86","first-page":"811","article-title":"Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV+ men","volume":"30","author":"Wagner","year":"1998","journal-title":"Medicine & Science in Sports and Exercise"},{"issue":"2","key":"10.1002\/14651858.CD005483-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0271-5317(98)00186-9","article-title":"Effects of testosterone on weight and body composition in men with human immunodeficiency virus-related weight loss","volume":"19","author":"Wagner","year":"1999","journal-title":"Nutr Res"},{"key":"10.1002\/14651858.CD005483-BIB0088|cit88","first-page":"Abstract no. 12","article-title":"Effects of oxandrolone on malnutition in HIV-infected children","volume":"12:35","author":"Wheeler","year":"1998","journal-title":"Int Conf AIDS"},{"key":"10.1002\/14651858.CD005483-BIB0089|cit89","first-page":"407","article-title":"Testosterone replacement increases fat-free mass and muscle size in hypogonadal men","volume":"82","author":"Bhasin","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1177\/014860719902300605","article-title":"Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection","volume":"23","author":"Bhasin","year":"1999","journal-title":"Jpen"},{"key":"10.1002\/14651858.CD005483-BIB0091|cit91","first-page":"3469","article-title":"Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study","volume":"81","author":"Brodsky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199906033402207","article-title":"Drug therapy: treatments for wasting in patients with the acquired immunodeficiency syndrome","volume":"340","author":"Corcoran","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1002\/14651858.CD005483-BIB0093|cit93","article-title":"Analysing and presenting results","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 8.8.1. In: The Cochrane Library, Issue 3","author":"Deeks","year":"2005"},{"key":"10.1002\/14651858.CD005483-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00126334-200306010-00024","article-title":"AIDS wasting syndrome: trends, influence on opportunistic infections, and survival","volume":"33","author":"Dworkin","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/14651858.CD005483-BIB0095|cit95","first-page":"4051","article-title":"Loss of lean body mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0096|cit96","first-page":"1332","article-title":"Body composition and endocrine function in women with acquired immunodeficieny syndrome wasting","volume":"82","author":"Grinspoon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD005483-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jamia.1994.95153434","article-title":"Developing optimal search strategies for detecting clinically sound studies in MEDLINE","volume":"1","author":"Haynes","year":"1994","journal-title":"J Am Med Inform Assoc"},{"key":"10.1002\/14651858.CD005483-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clin Trials"},{"key":"10.1002\/14651858.CD005483-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1001\/jama.1989.03430220089036","article-title":"Hooked on hormones? An anabolic steroid addiction hypothesis","volume":"262","author":"Kashkin","year":"1989","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005483-BIB0100|cit100","first-page":"403","article-title":"Wasting","volume-title":"The AIDS Knowledge Base","author":"Mulligan","year":"1999"},{"key":"10.1002\/14651858.CD005483-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: Dimensions of methodological qualtiy associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005483-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/aje\/kwf039","article-title":"Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999","volume":"156","author":"Smit","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1002\/14651858.CD005483-BIB0103|cit103","first-page":"1635","article-title":"Androgens","volume-title":"Goodman and Gillman's the pharmacological basis of therapeutics","author":"Snyder","year":"2001"},{"key":"10.1002\/14651858.CD005483-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcn\/56.1.19","article-title":"The five-level model: a new approach to organizing body-composition research","volume":"56","author":"Wang","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1002\/14651858.CD005483-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1086\/314027","article-title":"Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy","volume":"31","author":"Wanke","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T12:47:35Z","timestamp":1750337255000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005483"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,10,19]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005483","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,19]]}}}